A new therapeutic target against the most common lung cancer

TIMP-1 protein levels in both tissues and blood have been repeatedly associated with a poor prognosis in lung cancers, but its role has been unknown. Now, a study led by Jordi Alcaraz, lecturer at the Faculty of Medicine and Health Sciences of the UB and researcher at the Institute for Bioengineering of Catalonia (IBEC), has determined that this protein is not only a good biomarker, but is also involved in the progression of lung adenocarcinoma. These results, published in the journal Matrix Biology, open the door to the design of new treatments against this disease.

HIV, TB, malaria fight saves 50 million lives over 20 years: Global Fund

The fight against HIV, tuberculosis and malaria has saved 50 million lives over the past 20 years, the Global Fund said Monday, appealing for $18 billion to save millions more.

Polycystic ovary syndrome is going undetected in Nigeria

Polycystic ovary syndrome is the most common gynecological endocrine disorder in women of reproductive age. It affects between 4% and 20% of women globally and is influenced by genetic and environmental factors. Despite its prevalence, it remains a conundrum amongst clinicians and allied health professionals. The Conversation Africa's Nigeria based commissioning editor Kofoworola Belo-Osagie asked public health lecturer Ajike Saratu Omagbemi to explain the syndrome and the challenges around how it's being detected.

Weight loss: The time of day you eat your biggest meal has little effect says new study

Some of the most popular diet advice in recent years has centered around the idea that the right timing for your meals can make a big difference in the amount of weight you lose. It was long said that if you wanted to lose weight it was best to eat a large meal at the beginning of the day and keep any later meals smaller.

Fungal infections increase mortality among hospitalized COVID-19 patients worldwide

Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them. However, in people with compromised immunity, such as transplant and cancer patients, as well as hospitalized patients in intensive care, the interaction between pathogen and host may be quite different.

TAVR is an affordable and effective strategy for treating aortic stenosis patients

Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized treatment of aortic stenosis (AS), and both American and European guidelines have approved its use. However, there is a perception that TAVR is more expensive than surgical aortic valve replacement (SAVR). A budget impact analysis comparing the two options now shows that TAVR is an affordable and effective strategy for the treatment of AS. The study appears in the Canadian Journal of Cardiology.

Americans give health care system failing mark: AP-NORC poll

When Emmanuel Obeng-Dankwa is worried about making rent on his New York City apartment, he sometimes holds off on filling his blood pressure medication.